The CyberKnife® Radiosurgery Solution
Early stage Bronchogenic Carcinoma: Conclusion Definitive surgery remains the “gold standard” for resectable early stage bronchogenic carcinoma in healthy patients. For early stage patients that are “medically unresectable” though, the CyberKnife® device is uniquely suited to deliver a tissue ablative radiation dose to a moving target lesion in the thorax, while preserving the maximum possible adjacent tissue, making it an ideal device to treat these patients.